Skip to main content
. 2020 Nov 20;8(2):e001860. doi: 10.1136/bmjdrc-2020-001860

Figure 3.

Figure 3

Associations between ratios of ceramides to dihydroceramides (ceramide/dihydroceramide) in serum (A–D, G), liver (E, F) or visceral fat (H) and body mass index (BMI), liver fat content, thiobarbituric acid reactive substances (TBARS) in serum and liver, whole-body insulin sensitivity (M-value), state U respiration in liver tissue and interleukin-6 (IL-6) in lean humans (blue) and obese persons without non-alcoholic fatty liver (yellow) or with NAFL (orange) or with non-alcoholic steatohepatitis (red). DHC, dihydroceramide; EGP, endogenous glucose production; NAFL, non-alcoholic fatty liver.